<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20205" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ovarian Cystadenoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mlika</surname>
            <given-names>Mouna</given-names>
          </name>
          <aff>University of Medicine of Tunis</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mouna Mlika declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>18</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20205.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Epithelial neoplasms of the ovary account for 60 percent of all ovarian tumors and 40 percent of benign tumors. They are classified as benign, borderline, or malignant tumors. Ovarian cystadenomas are common benign epithelial neoplasms that carry an excellent prognosis. This activity reviews the cause and pathophysiology of ovarian cystadenoma and the role of the interprofessional team in management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the types of ovarian cystadenomas.</p></list-item><list-item><p>Describe the presentation of ovarian cystadenoma.</p></list-item><list-item><p>Summarize the treatment options for ovarian cystadenoma.</p></list-item><list-item><p>Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by ovarian cystadenomas.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20205&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20205">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20205.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Epithelial neoplasms of the ovary account for 60% of all ovarian&#x000a0;tumors and 40% of benign tumors.<xref ref-type="bibr" rid="article-20205.r1">[1]</xref> They classify as benign, borderline, or malignant tumors. Ovarian cystadenomas are common benign epithelial neoplasms which carry an excellent prognosis.&#x000a0;The two most&#x000a0;frequent types of&#x000a0;cystadenomas are serous and mucinous cystadenomas&#x000a0;whereas&#x000a0;endometrioid and clear&#x000a0;cell&#x000a0;cystadenomas are rare. Despite&#x000a0;advances in imaging studies, the establishment of a definitive diagnosis&#x000a0;of cystadenomas&#x000a0;is primarily by histopathological examination of the surgical specimen.&#x000a0;This review will focus on ovarian cystadenomas and their histopathological features.</p>
      </sec>
      <sec id="article-20205.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>Serous Cystadenoma</bold>
</p>
        <p>Serous cystadenomas do not have mutations in either KRAS or BRAF in contrast to serous&#x000a0;borderline tumors and low-grade&#x000a0;serous&#x000a0;carcinoma. Most serous cystadenomas are polyclonal, but monoclonal cystadenomas occur. They develop as a hyperplastic expansion from epithelial inclusions.<xref ref-type="bibr" rid="article-20205.r2">[2]</xref> Serous cystadenomas show DNA copy number changes in the epithelial cells in some cases.<xref ref-type="bibr" rid="article-20205.r2">[2]</xref></p>
        <p>
<bold>Mucinous Cystadenoma</bold>
</p>
        <p>The association of mucinous cystadenomas with dermoid cysts indicates&#x000a0;that some are of germ cell origin and an association with Brenner tumors implies a surface epithelial origin for another subset.<xref ref-type="bibr" rid="article-20205.r3">[3]</xref> KRAS mutations are present in up to 58% of cases.<xref ref-type="bibr" rid="article-20205.r4">[4]</xref></p>
        <p>
<bold>Endometrioid Cystadenoma</bold>
</p>
        <p>Morphological and molecular genetic studies have implicated endometriotic cysts and endometriosis in the development of endometrioid, clear cell, and seromucinous tumors.&#x000a0;</p>
        <p>
<bold>Seromucinous Cystadenoma</bold>
</p>
        <p>According to some authors, seromucinous cystadenomas likely derive from endometriosis.<xref ref-type="bibr" rid="article-20205.r5">[5]</xref></p>
      </sec>
      <sec id="article-20205.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>
<bold>Serous Cystadenoma</bold>
</p>
        <p>Benign serous tumors of the ovary represent 16% of all ovarian epithelial neoplasms and account for two-thirds of benign ovarian epithelial tumors and&#x000a0;the majority&#x000a0;of&#x000a0;serous ovarian&#x000a0;tumors.&#x000a0;They occur in adults of all ages, with reported mean ages&#x000a0;differing&#x000a0;from 40 to 60 years.<xref ref-type="bibr" rid="article-20205.r6">[6]</xref> They are bilateral in 10 to 20% of the cases.</p>
        <p>
<bold>Mucinous Cystadenoma</bold>
</p>
        <p>Benign mucinous cystadenomas account for 80% of ovarian mucinous tumors. Mucinous cystadenomas of the&#x000a0;ovary occur mainly in during the third to sixth&#x000a0;decades, but they&#x000a0;may also occur in younger women.<xref ref-type="bibr" rid="article-20205.r7">[7]</xref> They are unilateral in 95% of the cases.&#x000a0;</p>
        <p>
<bold>Endometrioid Cystadenoma</bold>
</p>
        <p>Endometrioid epithelial tumors&#x000a0;account for 2 to 4% of all ovarian tumors. They usually occur in the&#x000a0;fourth and fifth decades.<xref ref-type="bibr" rid="article-20205.r8">[8]</xref> Endometrioid tumors often correlate with endometriosis.&#x000a0;</p>
        <p>
<bold>Clear Cell Cystadenoma</bold>
</p>
        <p>Clear cell cystadenoma is very rare with very few cases reported in the literature.<xref ref-type="bibr" rid="article-20205.r9">[9]</xref></p>
        <p>
<bold>Seromucinous Cystadenoma</bold>
</p>
        <p>Seromucinous&#x000a0;cystadenoma occurs in adults with a peak in the late reproductive age group.<xref ref-type="bibr" rid="article-20205.r10">[10]</xref></p>
      </sec>
      <sec id="article-20205.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Serous Cystadenoma</bold>
</p>
        <p><italic toggle="yes">Macroscopic findings</italic>:</p>
        <p>Serous cystadenoma ranges in size from 1 to more than&#x000a0;30 cm in greatest dimension (mean = 10 cm). They have a smooth outer surface and contain one or more thin-walled cysts filled with clear, watery&#x000a0;fluid.<xref ref-type="bibr" rid="article-20205.r6">[6]</xref> Serous&#x000a0;cystadenomas are usually unilocular but may be multilocular.&#x000a0;</p>
        <p><italic toggle="yes">Histopathology</italic>:</p>
        <p>Serous cystadenomas are composed of cysts and papillae lined by non-stratified or stratified cuboidal to columnar cells resembling fallopian tube epithelium.<xref ref-type="bibr" rid="article-20205.r6">[6]</xref> Usually, there is no or minimal atypia.</p>
        <p>
<italic toggle="yes">Immunohistochemistry:</italic>
</p>
        <p>The immunohistochemical profile of serous&#x000a0;cystadenoma is similar to that of normal ovarian surface epithelium and tubal epithelium. In addition to positivity with most commonly used epithelial markers, p63 is positive in most cases.<xref ref-type="bibr" rid="article-20205.r11">[11]</xref></p>
        <p>
<bold>Mucinous Cystadenoma</bold>
</p>
        <p>
<italic toggle="yes">Macroscopic findings:&#x000a0;</italic>
</p>
        <p>Mucinous cystadenomas have a smooth surface and are usually multilocular and sometimes unilocular. They range in size from a few centimeters to greater than 30 cm; with a mean of 10 cm.&#x000a0;</p>
        <p>
<italic toggle="yes">Histopathology:</italic>
</p>
        <p>Mucinous cystadenoma&#x000a0;is composed&#x000a0;of multiple cysts and glands lined by simple non-stratified mucinous epithelium resembling gastric foveolar-type or intestinal epithelium containing goblet cells and sometimes neuroendocrine cells or Paneth cells. &#x000a0;The ovarian stroma&#x000a0;may be cellular with areas of stromal luteinization.&#x000a0;There&#x000a0;are&#x000a0;no cytologic atypia and no mitotic figures.</p>
        <p>
<bold>Endometrioid Cystadenoma</bold>
</p>
        <p><italic toggle="yes">Macroscopic findings: </italic>the cysts range in size up to 15 cm. The cyst lining is irregular with areas of hemorrhage. The cyst contents are typically dark brown due to old hemorrhage (chocolate cyst).</p>
        <p><italic toggle="yes">Histopathology:&#x000a0;</italic>the rare endometrioid cystadenomas are similar to endometriotic cysts but lack endometrial stroma, hemosiderin-laden macrophages, and a myofibroblastic wall.&#x000a0;There&#x000a0;are&#x000a0;no cytologic atypia and no mitotic figures.</p>
        <p>
<bold>Clear Cell Cystadenoma</bold>
</p>
        <p>
<italic toggle="yes">Macroscopic findings: </italic>
</p>
        <p>Clear cell cystadenoma ranges in size from 3 to 16 cm. It has a&#x000a0;smooth, lobulated external surface.</p>
        <p>
<italic toggle="yes">Histopathology:</italic>
</p>
        <p>Clear cell cystadenoma is composed of glands or cysts lined by cuboidal to flattened cells with clear or eosinophilic cytoplasm embedded in a fibromatous stroma. There&#x000a0;are no cytologic atypia and no mitotic figures.&#x000a0;</p>
        <p>
<bold>Seromucinous Cystadenoma</bold>
</p>
        <p><italic toggle="yes">Macroscopic findings</italic>:&#x000a0;</p>
        <p>Grossly,&#x000a0;seromucinous cystadenomas present as a unilocular cyst with a smooth surface and inner lining. They may contain serous or mucinous fluid.</p>
        <p><italic toggle="yes">Histopathology</italic>:</p>
        <p>Histologically, the cysts&#x000a0;are lined&#x000a0;by a variable&#x000a0;admixture&#x000a0;of serous and mucinous cells (endocervical-type) but endometrial and less often transitional or squamous cells may be in evidence. If present, the stroma is bland and fibromatous.&#x000a0;</p>
      </sec>
      <sec id="article-20205.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Ovarian cystadenomas&#x000a0;ranging in size from 1 to 3 cm are usually incidental findings&#x000a0;and reveal themselves during&#x000a0;an ultrasound&#x000a0;investigation of another gynecologic disorder.<xref ref-type="bibr" rid="article-20205.r12">[12]</xref></p>
        <p>The symptoms and signs associated with large tumors are nonspecific and most commonly include<xref ref-type="bibr" rid="article-20205.r6">[6]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pelvic pain</p>
          </list-item>
          <list-item>
            <p>Bloating</p>
          </list-item>
          <list-item>
            <p>Discomfort</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20205.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Serum CA-125 Assay</bold>
</p>
        <p>Serum CA-125 assay is a useful tool that helps to distinguish&#x000a0;between benign and malignant&#x000a0;ovarian masses. The combination of normal findings at serum CA-125 assay, imaging, and clinical findings exclude the possibility of ovarian cancer.<xref ref-type="bibr" rid="article-20205.r12">[12]</xref></p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <p>Several imaging techniques are useful for the diagnosis of ovarian cystadenomas. They include<xref ref-type="bibr" rid="article-20205.r13">[13]</xref><xref ref-type="bibr" rid="article-20205.r12">[12]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pelvic ultrasonography (US)</p>
          </list-item>
          <list-item>
            <p>Computed tomography</p>
          </list-item>
          <list-item>
            <p>Magnetic resonance imaging</p>
          </list-item>
        </list>
        <p>The features that are more suggestive of a benign cystic neoplasm include<xref ref-type="bibr" rid="article-20205.r12">[12]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Unilocularity of cysts</p>
          </list-item>
          <list-item>
            <p>Minimal septations</p>
          </list-item>
          <list-item>
            <p>Thin walls</p>
          </list-item>
          <list-item>
            <p>and absence of papillary projections</p>
          </list-item>
        </list>
        <p>The cell type of cystadenomas&#x000a0;cannot be determined based on imaging findings.&#x000a0;</p>
        <p>
<italic toggle="yes">Ultrasonography:</italic>
</p>
        <p>The initial imaging study recommended in the evaluation of adnexal masses is the&#x000a0;pelvic US. The transabdominal&#x000a0;US or&#x000a0;the endo-vaginal&#x000a0;US should is the study of choice to evaluate ovarian masses.<xref ref-type="bibr" rid="article-20205.r12">[12]</xref></p>
        <p>
<italic toggle="yes">Computed tomography:</italic>
</p>
        <p>Although CT is a&#x000a0;useful imaging technique in diagnosing adnexal masses, it is&#x000a0;sometimes of limited value.<xref ref-type="bibr" rid="article-20205.r12">[12]</xref></p>
        <p>
<italic toggle="yes">Magnetic resonance imaging:</italic>
</p>
        <p>Benign epithelial ovarian neoplasms are predominantly cystic,&#x000a0;in contrast to malignant epithelial neoplasms which comprise both cystic and solid components. Cystic lesions containing simple fluid have prolonged T1 and T2 relaxation times and very&#x000a0;high signal intensity on T2- weighted images.<xref ref-type="bibr" rid="article-20205.r12">[12]</xref></p>
        <p>
<bold>Histopathology</bold>
</p>
        <p>The definitive diagnosis of ovarian cystadenomas is based on histopathological examination of the surgical specimen.</p>
      </sec>
      <sec id="article-20205.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of ovarian cystadenomas depends on the following factors<xref ref-type="bibr" rid="article-20205.r14">[14]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Symptoms</p>
          </list-item>
          <list-item>
            <p>Size of the cyst</p>
          </list-item>
          <list-item>
            <p>Age of the patient</p>
          </list-item>
          <list-item>
            <p>Medical history</p>
          </list-item>
          <list-item>
            <p>Menopausal state of the patient</p>
          </list-item>
        </list>
        <p>Unilateral salpingo-oophorectomy or ovarian cystectomy is the adequate treatment of ovarian cystadenomas.</p>
        <p>Clinical recurrence is uncommon and reflects either incomplete resection or a new primary tumor.</p>
      </sec>
      <sec id="article-20205.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Histological Differential Diagnosis</bold>
</p>
        <p>
<bold>Serous Cystadenoma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Broad ligament cysts
<list list-type="bullet"><list-item><p>Hydatid cyst of Morgani</p></list-item><list-item><p>Mesonephric cysts</p></list-item><list-item><p>Mesothelial cysts</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Extensive cortical inclusion cysts&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cystically dilated follicles</p>
          </list-item>
          <list-item>
            <p>Paratubal cysts</p>
          </list-item>
          <list-item>
            <p>Hydrosalpinx</p>
          </list-item>
          <list-item>
            <p>Cystic struma ovarii</p>
          </list-item>
          <list-item>
            <p>Rete cystadenomas</p>
          </list-item>
          <list-item>
            <p>Polycystic ovarian disease</p>
          </list-item>
        </list>
        <p>
<bold>Mucinous Cystadenoma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cystic mature teratoma</p>
          </list-item>
        </list>
        <p>
<bold>Endometrioid Cystadenoma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0;Serous cystadenofibroma</p>
          </list-item>
        </list>
        <p>
<bold>Seromucinous Cystadenoma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Serous cystadenoma</p>
          </list-item>
          <list-item>
            <p>Mucinous cystadenoma</p>
          </list-item>
          <list-item>
            <p>Cystic mature teratoma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20205.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>
<bold>Serous Cystadenoma</bold>
</p>
        <p>Serous cystadenomas are benign lesions, but they may occasionally recur after cystectomy.<xref ref-type="bibr" rid="article-20205.r13">[13]</xref></p>
        <p>
<bold>Mucinous Cystadenoma</bold>
</p>
        <p>Mucnous cystadenomas are benign. However, recurrences may be seen in cases treated with cystectomy.<xref ref-type="bibr" rid="article-20205.r7">[7]</xref></p>
        <p>
<bold>Endometrioid Cystadenoma</bold>
</p>
        <p>Endometrioid cystadenomas are benign lesions which carry an excellent prognosis.&#x000a0; Although these tumors do, rarely recur.&#x000a0;&#x000a0;</p>
        <p>
<bold>Clear Cell Cystadenoma</bold>
</p>
        <p>Clear cell cystadenoma is a benign cyst with an excellent prognosis.</p>
      </sec>
      <sec id="article-20205.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Cystadenomas of the ovary are benign lesions that rarely recur after incomplete resection.</p>
        <p>Rare complications of ovarian cystadenomas include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ovarian torsion</p>
          </list-item>
          <list-item>
            <p>Cyst rupture</p>
          </list-item>
        </list>
        <p>There is a risk of development of&#x000a0;pseudomyxoma&#x000a0;peritonei&#x000a0;if a mucinous cystadenoma ruptures.</p>
      </sec>
      <sec id="article-20205.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Ovarian cystadenomas are benign tumors which carry an excellent prognosis. They&#x000a0;are&#x000a0;ideally managed&#x000a0;by an interprofessional team that consists of&#x000a0;gynecologists, radiologists, and pathologists.&#x000a0;</p>
      </sec>
      <sec id="article-20205.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20205&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20205">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/ovarian-cystadenoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20205">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20205/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20205">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20205.s14">
        <fig id="article-20205.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Ovary cystadenoma Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ovarian__cystadenoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-20205.s15">
        <fig id="article-20205.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Serous cystadenoma, multiloculated cyst wall with monostratified serous epithelium. 10x H/E stain. Contributed by Fabiola Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="serous02" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20205.s16">
        <title>References</title>
        <ref id="article-20205.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buy</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Ghossain</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sciot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bazot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guinet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pr&#x000e9;vot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hugol</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Laromiguiere</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Truc</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Poitout</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Epithelial tumors of the ovary: CT findings and correlation with US.</article-title>
            <source>Radiology</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>178</volume>
            <issue>3</issue>
            <fpage>811</fpage>
            <page-range>811-8</page-range>
            <pub-id pub-id-type="pmid">1994423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunter</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Anglesio</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gilks</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Melnyk</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chiew</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>deFazio</surname>
                <given-names>A</given-names>
              </name>
              <collab>Australian Ovarian Cancer Study Group</collab>
              <name>
                <surname>Longacre</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Huntsman</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Gorringe</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>IG</given-names>
              </name>
            </person-group>
            <article-title>Copy number aberrations in benign serous ovarian tumors: a case for reclassification?</article-title>
            <source>Clin Cancer Res</source>
            <year>2011</year>
            <month>Dec</month>
            <day>01</day>
            <volume>17</volume>
            <issue>23</issue>
            <fpage>7273</fpage>
            <page-range>7273-82</page-range>
            <pub-id pub-id-type="pmid">21976534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seidman</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Khedmati</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>11</issue>
            <fpage>1753</fpage>
            <page-range>1753-60</page-range>
            <pub-id pub-id-type="pmid">18976011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cuatrecasas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Villanueva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matias-Guiu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Prat</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases.</article-title>
            <source>Cancer</source>
            <year>1997</year>
            <month>Apr</month>
            <day>15</day>
            <volume>79</volume>
            <issue>8</issue>
            <fpage>1581</fpage>
            <page-range>1581-6</page-range>
            <pub-id pub-id-type="pmid">9118042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massicot</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rousseau</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Darwish</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Sauvat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jaubert</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nihoul-F&#x000e9;k&#x000e9;t&#x000e9;</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Serous and seromucinous infantile ovarian cystadenomas--a study of 42 cases.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>142</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-7</page-range>
            <pub-id pub-id-type="pmid">18996636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seidman</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Mehrotra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Benign ovarian serous tumors: a re-evaluation and proposed reclassification of serous "cystadenomas" and "cystadenofibromas".</article-title>
            <source>Gynecol Oncol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>96</volume>
            <issue>2</issue>
            <fpage>395</fpage>
            <page-range>395-401</page-range>
            <pub-id pub-id-type="pmid">15661227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mishra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walawakar</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Giant Ovarian Mucinous Cystadenoma Complicating Term Pregnancy.</article-title>
            <source>JNMA J Nepal Med Assoc</source>
            <year>2018</year>
            <season>Mar-Apr</season>
            <volume>56</volume>
            <issue>210</issue>
            <fpage>629</fpage>
            <page-range>629-632</page-range>
            <pub-id pub-id-type="pmid">30376010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bell</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Scully</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases.</article-title>
            <source>Am J Surg Pathol</source>
            <year>1985</year>
            <month>Mar</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-14</page-range>
            <pub-id pub-id-type="pmid">3993832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jung</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Eom</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Byun</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YN</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Different features of the histopathological subtypes of ovarian tumors in pre- and postmenopausal women.</article-title>
            <source>Menopause</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>1028</fpage>
            <page-range>1028-1032</page-range>
            <pub-id pub-id-type="pmid">28832426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seidman</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ovarian Epithelial Inclusions With Mucinous Differentiation: A Clinicopathologic Study of 42 Cases.</article-title>
            <source>Int J Gynecol Pathol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>372</fpage>
            <page-range>372-376</page-range>
            <pub-id pub-id-type="pmid">27801756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poli Neto</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Candido Dos Reis</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Zambelli Ramalho</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>de Andrade</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>p63 expression in epithelial ovarian tumors.</article-title>
            <source>Int J Gynecol Cancer</source>
            <year>2006</year>
            <season>Jan-Feb</season>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>152</fpage>
            <page-range>152-5</page-range>
            <pub-id pub-id-type="pmid">16445626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeong</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Outwater</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>Imaging evaluation of ovarian masses.</article-title>
            <source>Radiographics</source>
            <year>2000</year>
            <season>Sep-Oct</season>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>1445</fpage>
            <page-range>1445-70</page-range>
            <pub-id pub-id-type="pmid">10992033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fatema</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mubarak Al Badi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A Postmenopausal Woman with Giant Ovarian Serous Cyst Adenoma: A Case Report with Brief Literature Review.</article-title>
            <source>Case Rep Obstet Gynecol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>5478328</fpage>
            <pub-id pub-id-type="pmid">29850314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20205.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzalez</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Minneci</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Deans</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Management of benign ovarian lesions in girls: a trend toward fewer oophorectomies.</article-title>
            <source>Curr Opin Obstet Gynecol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>289</fpage>
            <page-range>289-294</page-range>
            <pub-id pub-id-type="pmid">28759460</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
